No Data
Catalyst Watch: Nvidia Event Could Revive Animal Spirits, Fed Meeting, and Nike Earnings
UPDATE: Federal Circuit Affirms Denial Of Preliminary Injunction In Regeneron Pharmaceuticals V. Amgen, Upholding District Court's Finding Of No Likelihood Of Success On Patent Infringement Of U.S. Patent 11,084,865 Covering Eylea
How Do Investors Really Feel About Alnylam Pharmaceuticals?
Is Gilead Sciences Gaining or Losing Market Support?
Amgen's Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year
FDA Commissioner Nominee Makary Advances to Full Senate Vote
